*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Pralatrexate is an antifolate chemotherapy agent designed for <strong>relapsed or refractory peripheral T-cell lymphoma (PTCL)</strong>. Manufactured via complex organic synthesis, its molecular formula is <strong>C21H24N8O6</strong> and CAS number is <strong>350876-75-2</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Therapy:</strong> Intravenous administration for adult PTCL patients.</li>
<li><strong>Clinical Research:</strong> Investigational use in combination regimens for hematologic malignancies.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in severe renal impairment. Requires <strong>folinic acid rescue</strong> to mitigate toxicity. Store under controlled conditions at 20°C to 25°C away from light and moisture.</p>